Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Hearing aids may slow memory loss in seniors, major trial hopes

NCT ID NCT05532657

Disease control Sponsor: Johns Hopkins University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jul 22, 2026 · Updated 3 times

Summary

This study follows 629 older adults for 3 years to see if using hearing aids and getting hearing rehab can slow down memory loss and lower the risk of dementia. Participants were already in an earlier trial and now continue with hearing care or a delayed treatment. The goal is to find out if treating hearing loss helps keep the brain healthy.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
hearing aids and hearing rehabilitation program
What this could lead to
If it works, this could show that treating hearing loss helps preserve memory and thinking skills in older adults.
What could go wrong
This is a follow-up study, so results may take years. Hearing aids may not prevent dementia, and benefits could be small or limited to certain people.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

629 people

The number who actually took part.

Started

Jan 2023

Expected to finish

May 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

73 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

To be eligible for ACHIEVE-BHFU, participants must meet the following criteria: * Eligible for and participated in the ACHIEVE trial (see original criteria below) * Agree to participate and are able and willing to comply with study procedures for three years in the follow-up study Original ACHIEVE Inclusion Criteria (during 2018-2019 enrollment): * Age 70-84 years * Community dwelling, fluent English speaker * Availability of participant in area for study duration * Adult-onset hearing impairment, defined as four-frequency pure tone average (PTA, 0.5-4 kilohertz (kHz), better ear) ≥ 30 decibels hearing level (dB HL) \& ≤ 70 dB HL * Speech recognition scores in quiet ≥ 60% in better ear * Mini-Mental State Exam (MMSE) score ≥ 23 for high school degree or less; ≥ 25 for some college or more Original ACHIEVE Exclusion Criteria: * Reported disability in ≥ 2 activities of daily living (ADLs) * Vision impairment (worse than 20/63 on the Minnesota Near Vision Card) * Self-reported use of a hearing aid in the past 1 year * Medical contraindication to use of hearing aids (e.g., draining ear) * Unwilling to wear hearing aids on a daily basis * Conductive hearing impairment with air-bone gap \> 15 dB (decibels) in two or more contiguous frequencies in both ears

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Aging are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Cognitive Dysfunction hearing loss disorder dementia prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Aging Cognitive decline Dementia Hearing loss Mild cognitive impairment

Contacts and locations

Locations

  • Johns Hopkins Comstock Center for Public Health Research and Prevention

    Hagerstown, Maryland, 21740, United States

  • University of Minnesota

    Minneapolis, Minnesota, 55415, United States

  • University of Mississippi Medical Center

    Jackson, Mississippi, 39216, United States

  • Wake Forest University

    Winston-Salem, North Carolina, 27104, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.